Clinical experience with a bioartificial liver in the treatment of severe liver failure: A phase I clinical trial

Annals of Surgery

Volumn 225, Issue 5, 1997, Pages 484-494

  Watanabe, Frederick D ^a   Mullon, Claudy J P ^b   Hewitt, Winston R ^a   Arkadopoulos, Nicholas ^a   Kahaku, Elaine ^a   Eguchi, Susumu ^a   Khalili, Theodore ^a   Arnaout, Walid ^a   Shackleton, Christopher R ^a   Rozga, Jacek ^a   Solomon, Barry ^b   Demetriou, Achilles A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Circe Biomedical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL LIVER; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER DYSFUNCTION; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 0031425422     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199705000-00005     Document Type: Article

References (25)

1. Lee WM. Acute liver failure. N Engl J Med 1993; 329:1862-1868.
2. Demetriou AA, Support of the Acutely Failing Liver. Medical Intel-Unit. Austin: RG Landes; 1994.
3. Bihari D, Hughes RD, Gimson AES, et al. Effect of serial resin in fulminant hepatic failure. Int J Artif Organs 1983; 6:299-302.
4. Gimson AES, Mellon PJ Braude S, et al. Earlier charcoal hemoperfusion in fulminant hepatic failure. Lancet 1982; ii:68-83.
5. Silk DBA, Trewby PN, Chase RA, et al. Treatment of fulminant failure by polyacrylonitrile membrane hemodialysis. Lancet 1977;ii:1-3.
6. Redeker AG, Yamahiro HS. Controlled trial of exchange transfusion in fulminant hepatitis. Lancet 1973; ii:3-6
7. Cooper GN, Karlson KE, Clowes GHA, et al. Total body washout and exchange. A valuable tool in acute hepatic coma and Reye's syndrome. Am J Surg 1977; 133:522-530.
8. Fox IJ, Langnas AN, Ozaki CF, et al. Successful application of extracorporeal liver perfusion for the treatment of fulminant hepatic failure; a technology whose time has come. Am J Gastroenterol 1993; 88:1876-1881.
9. Chari RS, Collins BH, Magee JC, et al. Brief report: treatment of hepatic failure with ex vivo pig liver perfusion followed by liver transplantation. N Engl J Med 1994; 331:234-237.
10. Olumide F, Eliashiv A, Kralios N, et al. Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer. Surgery 1977; 82:599-606.
11. Matsumura KN, Guevara GR, Houston H, et al. Hybrid bioartificial liver in hepatic failure: preliminary clinical report. Surgery 1987; 101:99-103.
12. Saito S, Sakagami K, Orita K. A new hybrid artificial liver using a combination of hepatocytes and biomatrix. Trans Am Soc Artif Organs 1987; 33:459-462.
13. Jauregui HO, Naik S, Driscoll J, et al. Adult rat hepatocyte cultures as the cellular component of an artificial hybrid liver. In: Paul JP, Galor JDS, Courtney JM, Gilchrist T, eds. Biomaterials in Artificial Organs. London: Macmillan; 1984:130-140.
14. Nyberg SL, Remmel PR, Mann HJ, et al. Primary hepatocytes outperform HepG2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg 1994; 220:59-67.
15. Sussman NL, Chong MG, Koussayir T, et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992; 16:60-65.
16. Neuzil DF, Rozga J, Moscioni AD, et al. Use of a novel bioartificial liver in a patient with acute liver insufficiency. Surgery 1993; 113:340-343.
17. Rozga J, Holzman MD, Ro MS, et al. Hybrid bioartificial liver support treatment of animals with severe ischemic liver failure. Ann Surg 1993; 217:502-511.
18. Rozga J, Williams F, Ro MS, et al. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 1993; 17:256-265.
19. Demetriou AA, Rozga J, Podesta L, et al. Early clinical experience with a bioartificial liver. Scand J Gastroenterol 1995; 30(Suppl 208):111-117.
20. Rozga J, LePage E, Moscioni AD, et al. Clinical use of a bioartificial liver to treat fulminant hepatic failure. Ann Surg 1994; 219:538-546.
21. Watanabe FD, Demetriou AA. Support of acute liver failure patients with a bioartificial liver. J Clin Apheresis 1996; 11:138-142.
22. Kamlot A, Rozga J, Watanabe FD, Demetriou AA. Review: artificial liver support systems. Biotech Bioeng 1996; 50:382-391.
23. Morsiani E, Rozga J, Scott HC, et al. Automated liver cell processing facilitates large-scale isolation and purification of porcine hepatocytes. ASAIO J 1995; 41:155-161.
24. Trey C, Davidson C. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Disease. New York: Grune & Stratton; 1970:282-298.
25. Record CO, Buxton B, Chase R, et al. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976; 6:387-394.